Protecting American Families and Servicemembers from Anthrax Act

House Bill

H.R. 2707

119th Congress

Protecting American Families and Servicemembers from Anthrax Act

In Committee

Introduced:Aug 12, 2025

Primary Sponsor

Donald G. Davis

Representative

Democratic

NC-1

Cosponsors

13

Quick Stats

Policy Area

Health

Summary

This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.

Latest Action

Referred to the Subcommittee on Health.

SponsorDonald G. Davis (D-NC)

Introduced8/12/2025

StatusReferred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Protecting American Families and Servicemembers from Anthrax Act

This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipme

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.

Bill Number: 2707
Sponsor: Donald G. Davis (D-NC)
Introduced: 8/12/2025
Status: Referred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Protecting American Families and Servicemembers from Anthrax Act
Bill Number: 2707
Sponsor: Donald G. Davis (D-NC)
Status: Referred to the Committee on Armed Services, and in addition to the Committee on Energy and Commerce
Introduced: 8/12/2025
Summary: This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products. Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone. The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.

Key Points

Main provisions of the bill

Establishes a tax credit of 25% for manufacturers of pharmaceuticals, medical products, and personal protective equipment located in designated distressed zones.
The tax credit increases to 30% if a substantial portion of the manufacturer's employees reside in the distressed zone.
Defines 'distressed zone' as an area designated as a qualified opportunity zone by the IRS with a poverty rate over 30%.
Intended to boost domestic production of critical medical supplies and reduce reliance on foreign imports.
Could incentivize companies to open or expand facilities in economically disadvantaged communities.

How This Impacts Americans

Potential effects on citizens and communities

If passed, this bill would primarily impact pharmaceutical and medical manufacturing companies, as well as residents of economically distressed communities where these facilities are located. It could lead to new job opportunities and investment in underserved areas, while also aiming to strengthen the domestic supply of important drugs and medical products.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2707, 119th Congress (2025). "Protecting American Families and Servicemembers from Anthrax Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-2707